Fact CheckerSign in

NCT06280183Completed

Functional Inspiratory Muscle Training in Obese Individuals

The Investigation of the Effects of Functional Inspiratory Muscle Training in Obese Individuals

Source: ClinicalTrials.gov · Last updated 27 Mar 2026

Brief summary (registry, in English)

In obese individuals, increased adipose tissue and systemic inflammation play a key role in the development of cardiometabolic diseases, pulmonary system dysfunction, and many respiratory diseases. Existing research has demonstrated beneficial clinical outcomes of inspiratory muscle training or combined aerobic and resistance exercise training in obese individuals. However, this focused on the isolated effects of exercise on obesity. In the current literature, no study is evaluating the effectiveness of functional inspiratory muscle training in obese individuals. This study aims to investigate the effects of functional inspiratory muscle training on body composition, cardiometabolic markers, functional capacity, respiratory function, respiratory muscle strength, and respiratory muscle performance in obese individuals.

Status (registry)
Completed
Study type
Interventional
Enrollment
45 (actual)
First submitted
26 Jan 2024
Start date
28 Feb 2024
Primary completion date
30 Aug 2025
Lead sponsor
Biruni University
Diseases
Obesity
NCT number
NCT06280183

What you commit to

  • Study type: Interventional
  • Participants enrolled: 45
  • From 28 Feb 2024 to the primary completion date, 30 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Functional class III or IV according to the New York Heart Association (NYHA) classification
  • Uncontrolled hypertension, diabetes and unstable angina pectoris
  • Cooperative disorders, orthopedic and neurological problems that may interfere with evaluation and treatment
  • Individuals with a history of lower extremity-related injury or surgery in the last six months
  • Being diagnosed with diabetes and having complications such as nephropathy, retinopathy and neuropathy
  • Those with accompanying chronic respiratory disease
  • Those with acute infection
  • Individuals with a history of spontaneous or trauma-related pneumothorax

Other

  • According to the World Health Organization (WHO) classification, body mass index is over 40 kg/m2
  • Those with a Charlson comorbidity score of 3 and above
  • Individuals with middle ear-related pathologies (such as tympanic membrane rupture, otitis)
  • Those with a STOP-Bang score of 3 and above
  • Smokers
  • Pregnancy

Who the study is looking for

  • Those between the ages of 25-60
  • According to the World Health Organization (WHO) classification, those with a body mass index between 30-40 kg/m2
  • Volunteering to participate in the research

Age in the registry: 25 years to 60 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Biruni University
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.